Progression-free survival as a surrogate endpoint for overall survival in patients with third-line or later-line chemotherapy for advanced gastric cancer

BACKGROUND: The correlation between overall survival (OS) and progression-free survival (PFS) has been evaluated in patients with metastatic or advanced gastric cancer who have received first-line and/or second-line chemotherapy. However, no corresponding analysis has been done for patients who have...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liya, Yu, Hao, Huang, Lihong, Shao, Fang, Bai, Jianling, Lou, Donghua, Chen, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410904/
https://www.ncbi.nlm.nih.gov/pubmed/25960663
http://dx.doi.org/10.2147/OTT.S82365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410904/
https://www.ncbi.nlm.nih.gov/pubmed/25960663
http://dx.doi.org/10.2147/OTT.S82365

Ejemplares similares